Upstage Lung Cancer Raises Awareness of the Changing Face of Lung Cancer


A dynamic and uplifting evening of live music hosted by WBZ’s Jordan Rich to strike a chord and raise awareness of the changing face of lung cancer.

Sensational 60’s: Classic Rock & Roll Lives On

A dynamic and uplifting evening of live music hosted by WBZ’s Jordan Rich to strike a chord and raise awareness of the changing face of lung cancer.April 27, 2017 │7:30 p.m. | Dana-Farber’s Boston Red Sox Jimmy Fund Auditorium

On April 27th at 7:30 p.m., Upstage Lung Cancer (ULC) in partnership with the Bonnie J. Addario Lung Cancer Foundation (ALCF) and the Dana-Farber Cancer Institute, presents Sensational 60’s: Classic Rock and Roll Lives On. SING OUT!, a spirited benefit concert at the Dana-Farber Boston Red Sox Jimmy Fund Auditorium. Concert proceeds will benefit the Upstage Lung Cancer Foundation Early Detection Project at the Dana-Farber Cancer Institute and the Addario Lung Cancer Medical Institute (ALCMI) Young Lung Genome Fund.

Tickets are complimentary for Lung Cancer survivors, $15 Students with ID, $25 general admission, $45 reserved, $100 (VIP) and $250 (Special VIP). To purchase tickets and for more information, visit

Hosted by WBZ’s Jordan Rich, this uplifting and up-tempo evening of the greatest hits from the ‘60s will strike a chord to raise awareness of the changing face of lung cancer. Performers include the Follen Angels performing jazz, cabaret, and Oldies pop, the a Cappella group, Custom Blend, and Northeastern University’s a Capella singers, NU Downbeats.

Guest speakers include Geoffrey Oxnard, MD, an oncologist at Dana-Farber who is a celebrated speaker, researcher, and clinician, and Anna Plaza of Addario Lung Cancer Foundation whose focus is young people with lung cancer.

Founded in Boston in 2008, ULC exclusively uses music and the performing arts to increase awareness, de-stigmatize the disease, and raise funds for cutting-edge early detection research. ULC’s founder and lung cancer survivor Hildy Grossman, and lead jazz vocalist of the cabaret group, Follen Angels, has combined her passions for life and song to bring awareness and hope to change the disturbing facts of lung cancer. Every two and half minutes someone is diagnosed with lung cancer, and increasingly those diagnoses happen in the prime of life and to those who never smoked. Lung cancer is the number one cancer killer, and more than 60% of patients are diagnosed at advanced stages when a cure is not feasible. The five-year survival rate for patients with advanced disease is less than 10%, but, if caught at the earliest stage, survival is greater than 70%. Grossman says: “We need a reliable and easily accessible method to detect lung cancer earlier. That’s what our concerts are for — Singing Out! to save lives. We can and must do something, and we can and must do that together. The time is now.”

The SING OUT! series is now in its fourth year. The rousing music from the ‘60s comes from one of the most memorable decades in our history. This exciting benefit event brings Boston’s musical and medical communities together for a common goal: to upstage lung cancer once and for all. “Music has the ability to heal in ways that are hard to explain. My own experience is that music has been my finest companion for joyful, stressful, challenging times. I am certainly not alone in this. We all remember songs throughout our lives that bring back memories and shape our moods. Upstage Lung Cancer is the only cancer organization that exclusively relies on music to achieve our mission. We guarantee a fabulous musical evening for young or old, no matter what your state of life. Please join us,” says Grossman who obviously loves what she and her organization are accomplishing.

Since its inception, ULC has partnered with the LUNGevity Foundation to fund over $2 million in research grants, including this year’s early detection grant to Lida Hariri, MD, Ph.D. of Massachusetts General Hospital. ULC continues to invest in the Young Lung Genome Project and Dana-Farber Early Detection of Lung Cancer Project.

Related Videos
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Beth Sandy on Incorporating Amivantamab and Mobocertinib into Clinical Practice for Patients With EGFR Exon 20 Insertion NSCLC
Experts on lung cancer
Experts on lung cancer
Experts on lung cancer
Experts on lung cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.